Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    NCT03553108
Previous Study | Return to List | Next Study

A Study Using Olaparib Tablets for Subjects With Advanced Solid Tumours. (IVIVC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03553108
Recruitment Status : Completed
First Posted : June 12, 2018
Last Update Posted : October 1, 2020
Sponsor:
Collaborators:
Iqvia Pty Ltd
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
AstraZeneca

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : March 12, 2019
Actual Study Completion Date : July 1, 2020